CHEMOTHERAPY FOR OVARIAN-CANCER

被引：7

作者：

KAYE, SB

机构：

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 04期

关键词：

D O I：

10.1016/S0959-8049(05)80168-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：632 / 635

页数：4

共 21 条

[1] CONTROLLING EMESIS RELATED TO CANCER-THERAPY [J].

AAPRO, MS .

EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) :356-361

[2]

[Anonymous], 1991, J CLIN ONCOL, V9, P1668

[3]

BELPOMME D, 1992, P AM SOC CLIN ONCOL, V10, P227

[4]

BOLIS G, 1992, P AN M AM SOC CLIN, V11, P225

[5] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[6] PREDICTION OF LONG-TERM SURVIVAL BY FLOW CYTOMETRIC ANALYSIS OF CELLULAR DNA CONTENT IN PATIENTS WITH ADVANCED OVARIAN-CANCER [J].

FRIEDLANDER, ML ;

HEDLEY, DW ;

SWANSON, C ;

RUSSELL, P .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (02) :282-290

[7] NEUROTOXIC SIDE-EFFECTS OF CISPLATIN [J].

HAMERS, FPT ;

GISPEN, WH ;

NEIJT, JP .

EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) :372-376

[8]

HOLE D, 1991, LANCET, V337, P611

[9] RANDOMIZED STUDY OF 2 DOSES OF CISPLATIN WITH CYCLOPHOSPHAMIDE IN EPITHELIAL OVARIAN-CANCER [J].

KAYE, SB ;

LEWIS, CR ;

PAUL, J ;

DUNCAN, ID ;

GORDON, HK ;

KITCHENER, HC ;

CRUICKSHANK, DJ ;

ATKINSON, RJ ;

SOUKOP, M ;

RANKIN, EM ;

CASSIDY, J ;

DAVIS, JA ;

REED, NS ;

CRAWFORD, SM ;

MACLEAN, A ;

SWAPP, GA ;

SARKAR, TK ;

KENNEDY, JH ;

SYMONDS, RP .

LANCET, 1992, 340 (8815) :329-333

[10] 2ND-LINE PLATINUM THERAPY IN PATIENTS WITH OVARIAN-CANCER PREVIOUSLY TREATED WITH CISPLATIN [J].

MARKMAN, M ;

ROTHMAN, R ;

HAKES, T ;

REICHMAN, B ;

HOSKINS, W ;

RUBIN, S ;

JONES, W ;

ALMADRONES, L ;

LEWIS, JL .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :389-393

← 1 2 3 →